HomeTBPH • NASDAQ
add
Theravance Biopharma Inc
Previous close
$17.68
Day range
$17.48 - $18.34
Year range
$7.90 - $20.33
Market cap
920.72M USD
Avg Volume
553.89K
P/E ratio
32.30
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 19.99M | 18.51% |
Operating expense | 18.33M | 8.64% |
Net income | 3.62M | 128.47% |
Net profit margin | 18.08 | 124.02% |
Earnings per share | 0.04 | 173.73% |
EBITDA | -6.05M | 31.61% |
Effective tax rate | 225.13% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 329.68M | 260.85% |
Total assets | 415.46M | 16.67% |
Total liabilities | 182.78M | 7.23% |
Total equity | 232.68M | — |
Shares outstanding | 50.67M | — |
Price to book | 3.85 | — |
Return on assets | -3.84% | — |
Return on capital | -5.88% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 3.62M | 128.47% |
Cash from operations | -6.51M | -25.25% |
Cash from investing | -100.25M | -476.16% |
Cash from financing | -400.00K | -7.53% |
Net change in cash | -107.15M | -366.56% |
Free cash flow | -13.18M | -1,140.37% |
About
Founded
2013
Website
Employees
97
